| scholarly article | Q13442814 |
| P2093 | author name string | Wang Y | |
| Harris DC | |||
| Wang YP | |||
| Lee VW | |||
| Alexander SI | |||
| Qin XH | |||
| Zheng GP | |||
| P2860 | cites work | Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production | Q24292957 |
| The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice | Q24670319 | ||
| Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation | Q24675931 | ||
| PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells | Q24677367 | ||
| Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor | Q28144319 | ||
| Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice | Q28201627 | ||
| Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses | Q28202175 | ||
| PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2 | Q28202803 | ||
| Expression of programmed death 1 ligands by murine T cells and APC | Q28214264 | ||
| The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis | Q28239517 | ||
| Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events | Q31442542 | ||
| Blockade of costimulatory pathways of T-cell activation: the solution to acute and chronic rejection? | Q33814500 | ||
| PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine | Q33950150 | ||
| Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression | Q33991001 | ||
| Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responses | Q34265788 | ||
| Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen | Q34290002 | ||
| Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis | Q34535189 | ||
| Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice | Q34543002 | ||
| Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. | Q34554699 | ||
| Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. | Q39737971 | ||
| The enhancement of aminonucleoside nephrosis by the co-administration of protamine | Q42212868 | ||
| B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis | Q44147199 | ||
| Programmed death-1 targeting can promote allograft survival | Q44223920 | ||
| C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis | Q45116503 | ||
| DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy | Q46480431 | ||
| Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism | Q47745301 | ||
| PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. | Q51995665 | ||
| Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. | Q54702814 | ||
| Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo | Q56902952 | ||
| PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis | Q81733758 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| P304 | page(s) | 1244-1250 | |
| P577 | publication date | 2006-08-09 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | A protective role for programmed death 1 in progression of murine adriamycin nephropathy. | |
| P478 | volume | 70 |
| Q46037111 | Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure. |
| Q55517938 | Minimal change disease associated with anti-PD1 immunotherapy: a case report. |
| Q47997273 | The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides. |
| Q61796094 | The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis |
| Q33791391 | The development of endometrial hyperplasia in aged PD-1-deficient female mice |
Search more.